{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:19:35Z","timestamp":1793899175393,"version":"4.8.0"},"reference-count":28,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjpo"],"accepted":{"date-parts":[[2024,5,12]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop evidence-based guidance for topical steroid use in paediatric eosinophilic oesophagitis (pEoE) in the UK for both induction and maintenance treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature review using Cochrane guidance was carried out by the British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) Eosinophilic Oesophagitis (EoE) Working Group (WG) and research leads to determine the evidence base for preparation, dosing and duration of use of swallowed topical steroid (STS) formulations in EoE. Seven themes relating to pEoE were reviewed by the WG, alongside the Cochrane review this formed the evidence base for consensus recommendations for pEoE in the UK. We provide an overview of practical considerations including treatment regimen and dosing. Oral viscous budesonide (OVB) and, if agreed by local regulatory committees, orodispersible budesonide (budesonide 1 mg tablets) were selected for ease of use and with most improvement in histology. A practical \u2018how to prepare and use\u2019 OVB appendix is included. Side effects identified included candidiasis and adrenal gland suppression. The use of oral systemic steroids in strictures is discussed briefly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>2638 citations were identified and 18 randomised controlled trials were included. Evidence exists for the use of STS for induction and maintenance therapy in EoE, especially regarding histological improvement. Using the Appraisal of Guidelines, Research and Evaluation criteria, dosing of steroids by age (0.5 mg two times per day &lt;10 years and 1 mg two times per day \u226510 years) for induction of at least 3 months was suggested based on evidence and practical consideration. Once histological remission is achieved, maintenance dosing of steroids appears to reduce the frequency and severity of relapse, as such a maintenance weaning regimen is proposed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A practical, evidence-based flow chart and guidance recommendations with consensus from the EoE WG and education and research representatives of BSPGHAN were developed with detailed practical considerations for use in the UK.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjpo-2023-002467","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T12:50:44Z","timestamp":1716468644000},"page":"e002467","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Swallowed topical steroid therapy for eosinophilic oesophagitis in children: practical, evidence-based guidance by the BSPGHAN Eosinophilic Oesophagitis Working Group"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7281-9619","authenticated-orcid":false,"given":"Joseph","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1216-5158","authenticated-orcid":false,"given":"Morris","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerryn","family":"Moolenschot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Jackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Gaynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cordell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Kannappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Furman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gasparetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus K H","family":"Auth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"2025010105253967000_8.1.e002467.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1502863"},{"key":"2025010105253967000_8.1.e002467.2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296781"},{"key":"2025010105253967000_8.1.e002467.3","first-page":"1419","article-title":"Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings","volume":"124","author":"Straumann","year":"1994","journal-title":"Schweiz Med Wochenschr"},{"key":"2025010105253967000_8.1.e002467.4","doi-asserted-by":"publisher","DOI":"10.1111\/APT.15231"},{"key":"2025010105253967000_8.1.e002467.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.06.067"},{"key":"2025010105253967000_8.1.e002467.6","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2012-301885.130","article-title":"The epidemiology and natural history of paediatric inflammatory bowel disease in a UK region: a prospective 14-year study","volume":"97","author":"Henderson","year":"2012","journal-title":"Arch Dis Child"},{"key":"2025010105253967000_8.1.e002467.7","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2022-102118"},{"key":"2025010105253967000_8.1.e002467.8","article-title":"Medical treatment of eosinophilic esophagitis","volume":"7","author":"Franciosi","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2025010105253967000_8.1.e002467.9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MPG.0000000000003530","article-title":"Characterization of eosinophilic esophagitis from the European pediatric eosinophilic esophagitis registry (pEEr) of ESPGHAN","volume":"75","author":"Oliva","year":"2022","journal-title":"J Pediatr Gastr Nutr"},{"key":"2025010105253967000_8.1.e002467.10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.dld.2020.11.025","article-title":"Systemic steroids have a role in treating esophageal strictures in paediatric eosinophilic esophagitis","volume":"53","author":"Hoofien","year":"2021","journal-title":"Dig Liver Dis"},{"key":"2025010105253967000_8.1.e002467.11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MPG.0000000000003482","article-title":"Pharmacokinetics of budesonide oral suspension in children and adolescents with eosinophilic esophagitis","volume":"75","author":"Gupta","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025010105253967000_8.1.e002467.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.03.025"},{"key":"2025010105253967000_8.1.e002467.13","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(11)60725-7","article-title":"Efficacy and safety of oral Budesonide suspension (OBS) in pediatric subjects with eosinophilic Esophagitis (Eoe): results from the double-blind, placebo-controlled PEER study","volume":"140","author":"Gupta","year":"2011","journal-title":"Gastroenterology"},{"key":"2025010105253967000_8.1.e002467.14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.07.039"},{"key":"2025010105253967000_8.1.e002467.15","unstructured":"Auth MKH , Chan J , Flynn D . Personal communication with A Cordell (Eosnetwork) and J Thompson (guts UK!). 2023."},{"key":"2025010105253967000_8.1.e002467.16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MPG.0000000000002537","article-title":"Adrenal insufficiency in children with eosinophilic esophagitis treated with topical corticosteroids","volume":"70","author":"Bose","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025010105253967000_8.1.e002467.17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/apt.14573","article-title":"Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis","volume":"47","author":"Philpott","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025010105253967000_8.1.e002467.18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MPG.0000000000003530","article-title":"Characterization of eosinophilic esophagitis in a multinational prospective pediatric cohort: initial report from the European pediatric eosinophilic esophagitis registry (pEEr) of ESPGHAN","volume":"75","author":"Oliva","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025010105253967000_8.1.e002467.19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MPG.0000000000002114","article-title":"Longitudinal growth outcomes following first-line treatment for pediatric patients with eosinophilic esophagitis","volume":"68","author":"Jensen","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025010105253967000_8.1.e002467.20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/MPG.0000000000002215","article-title":"Pediatric eosinophilic esophagitis: results of the retrospective pediatric eosinophilic esophagitis registry (retropeer)","volume":"68","author":"Hoofien","year":"2019","journal-title":"J Pediatr Gastroenterolg Nutr"},{"key":"2025010105253967000_8.1.e002467.21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/MPG.0000000000003834","article-title":"Variability in swallowed topical corticosteroid practice patterns for treatment of pediatric eosinophilic esophagitis","volume":"77","author":"Syverson","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025010105253967000_8.1.e002467.22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/MPG.0000000000003948","article-title":"Pooled phase 2 and 3 efficacy and safety data on budesonide oral suspension in adolescents with eosinophilic esophagitis","volume":"77","author":"Mukkada","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025010105253967000_8.1.e002467.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003950","article-title":"Artificial sweeteners and cancer risk: results from the nutrinet-sant\u00e9 population-based cohort stud","volume":"19","author":"Debras","year":"2022","journal-title":"PLoS Med"},{"key":"2025010105253967000_8.1.e002467.24","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/dc23-0206","article-title":"Artificial sweeteners and risk of type 2 diabetes in the prospective nutrinet-sant\u00e9 cohort.diabetes care","volume":"46","author":"Debras","year":"2023","journal-title":"Diabetes Care"},{"key":"2025010105253967000_8.1.e002467.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071204","article-title":"Artificial sweeteners and risk of cardiovascular diseases: results from the prospective nutrinet-sant\u00e9 cohort","volume":"378","author":"Debras","year":"2022","journal-title":"BMJ"},{"key":"2025010105253967000_8.1.e002467.26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/MPG.0000000000003948","article-title":"Pooled phse 2 and 3 efficacy and safety data on budesonide oral suspension in adolescents with eosinophilic oesophagitis","volume":"77","author":"Mukkada","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025010105253967000_8.1.e002467.27","unstructured":"Lucendo AJ , Antunes H , Papadopoulou A , et al . Budesonide oral suspension is effective and safe in pediatric eosinophilic Esophagitis (EoE): results from the induction phase of the randomised, double-blind, placebo-controlled trial PEDEOS-1. Abstracts submitted to UEGW and ESPGHAN; 2024"},{"key":"2025010105253967000_8.1.e002467.28","unstructured":"Amil Dias J , Salvatore S , Papadoloulou A , et al . Updated guidelines for diagnosis and management of eosinophilic esophagitis in pediatrics. Position paper for diagnosis and management by the EGID working group of ESPGHAN [in print]. J Pediatr Gastroenterol Nutr 2024."}],"container-title":["BMJ Paediatrics Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjpo-2023-002467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T08:27:19Z","timestamp":1735720039000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpaedsopen.bmj.com\/lookup\/doi\/10.1136\/bmjpo-2023-002467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,5,23]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/bmjpo-2023-002467"],"URL":"https:\/\/doi.org\/10.1136\/bmjpo-2023-002467","relation":{},"ISSN":["2399-9772"],"issn-type":[{"value":"2399-9772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}